miscellaneous for COVID-19 - living meta-analysis of clinical studies

meta|evidence COVID-19

Living systematic review and meta-analysis

vs. potential COVID-19 treatments
vs. control
vs. placebo
vs. standard of care

All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
root
secondary prevention

Studies
Mapping
Meta-analysis
Excluded 0

table network network 2

display ongoing demontrated benefit only

popup

ChiCTR2000030328, 0 ChiCTR2000030328

acetylcysteine vs. placebo

COVID 19 all comers

ChiCTR2000030471, 0 ChiCTR2000030471

alpha lipoic acid vs. adalimumab

COVID 19 all comers

COVID-AIV, 0 NCT04311697

aviptadil vs. placebo

COVID 19 all comers

Gunst JD, 2021 NCT04321096

camostat mesilate vs. placebo

COVID 19 all comers

EC-COVID-RCT, 0 NCT04326075

continuous positive airway pressure (CPAP) vs. standard of care

COVID 19 all comers

ChiCTR2000030055, 0 ChiCTR2000030055

dipyridamol vs. standard of care

COVID 19 all comers

NCT04321993, 0 NCT04321993

miscellaneous vs. standard of care

COVID 19 all comers

NCT04280224, 0 NCT04280224

natural killer (NK) cells vs. standard of care

COVID 19 all comers

NCT04312997, 0 NCT04312997

PUL-042 inhalation solution vs. placebo

COVID 19 all comers

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -

Extraction panel open

An extraction panel is open